Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Apr 28, 2026
STMicroelectronics (STM): Q1 2026 Revenue Climbs +23% YoY, Beats Estimates on AI and Automotive Momentum

STMicroelectronics (STM): Q1 2026 Revenue Climbs +23% YoY, Beats Estimates on AI and Automotive Momentum

Key Takeaways

  • STMicroelectronics reported Q1 2026 net revenues of $3.10 billion, up 23% year-over-year and beating consensus estimates of approximately $3.05 billion.
  • GAAP gross margin reached 33.8%, with non-GAAP gross margin at 34.1%, above the midpoint of guidance.
  • Non-GAAP diluted earnings per share (EPS) came in at $0.13, up 85.7% year-over-year but missing analyst expectations of around $0.18.
  • Q2 2026 guidance projects net revenues of $3.45 billion at the midpoint, signaling 11.6% sequential growth.
  • Strong bookings and AI-driven demand position data center revenues to exceed $500 million for full-year 2026.
  • Shares surged over 6% in premarket trading following the release, reflecting optimism despite the EPS miss.

Earnings Context: Why These Results Matter for STM Investors

STMicroelectronics (STM), a key player in semiconductors for automotive, industrial, and consumer electronics, has just shared its Q1 2026 results as the chip sector shows signs of recovery. Following a tough 2025 marked by inventory adjustments, these figures point to strengthening demand, especially in AI infrastructure and personal electronics. From what I see, investors like us are focused on whether this signals a lasting rebound, margin improvements, and smooth execution on moves like the NXP MEMS sensor acquisition. With auto production picking up globally and AI data center opportunities on the rise, this report sheds light on STM's edge over peers such as NXP and Infineon—shaping stock valuations and overall sector outlook in these uncertain times.

Breaking Down the Reported Q1 Numbers

On April 23, 2026, STMicroelectronics released its Q1 2026 results for the quarter ended March 28, 2026. Net revenues hit $3.095 billion, down 7% from the prior quarter but up 23% year-over-year, clearing both the company's guidance midpoint and consensus estimates of $3.05 billion. I also checked this using Tickeron’s AI Screener to see how STM stacks up against industry peers, and the growth stemmed from stronger sales in personal electronics and cloud-edge computing products (CECP), though partly offset elsewhere.

GAAP gross margin improved to 33.8%, up 40 basis points year-over-year, while non-GAAP gross margin—excluding Purchase Price Allocation (PPA) effects from the NXP acquisition—was 34.1%. GAAP operating income stood at $70 million, non-GAAP at $171 million. GAAP net income was $37 million, or $0.04 diluted EPS; non-GAAP net income reached $122 million, or $0.13 per diluted share, which fell short of consensus by about $0.05.

Segment-wise, Automotive, Microcontrollers & Sensors (AM&S) delivered $1.318 billion in revenues, up 23.2% year-over-year. Personal Computers & Displays (P&D) came in at $389 million, down 1.8%. Other areas like EMP and RFOC posted solid growth. Management highlighted strong bookings and normalized distribution inventory as encouraging signs.

Market Reaction and What Investors Are Focusing On

STM shares rose more than 6% in premarket trading after the release, pushing toward recent highs. The revenue beat and positive Q2 guidance overshadowed the EPS miss, with the market latching onto robust demand indicators, bookings strength, and AI exposure as proof of sector recovery. In my view, sentiment is cautiously optimistic, though execution will be key amid macro challenges and competitive pressures.

A Tool I Rely On for Deeper Insights: Tickeron’s AI Screener

One resource I turn to regularly in my analysis is Tickeron’s AI Screener, an AI-powered tool for discovering stocks and ETFs. It lets me filter thousands of names using technical patterns, fundamentals, trends, volatility, and AI signals—customizing by industry, market cap, indicators, price patterns, and performance metrics. This streamlines finding trade ideas, breakout candidates, and opportunities far faster than manual scans, enhancing my research process. I’ve found it particularly useful for sizing up STM in context.

Forward Outlook: Q2 Guidance and Key Metrics to Track

STMicroelectronics guided Q2 2026 net revenues to $3.45 billion at the midpoint, implying 11.6% sequential growth and 24.9% year-over-year. GAAP gross margin is expected at 34.8% (including ~100 basis points of unused capacity charges), with non-GAAP at 35.2%. This reflects ongoing momentum in customer programs and better market dynamics.

One thing that stands out is the push toward full-year data center revenues over $500 million in 2026, scaling above $1 billion in 2027, fueled by AI infrastructure. I’m watching segments like Automotive & Discrete & Power (AM&S), the NXP MEMS integration and its PPA effects closely. Broader trends in semiconductor inventory normalization, auto production, and supply chain geopolitics will matter too. Strong bookings suggest upside potential, but keep an eye on margin strains from unused capacity and restructuring. Next up: Q2 results in July and AI program updates.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: STM

Momentum Indicator for STM turns positive, indicating new upward trend

STM saw its Momentum Indicator move above the 0 level on September 22, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned positive. In 70 of the 92 cases, the stock moved higher in the following days. The odds of a move higher are at 76%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

STM moved above its 50-day moving average on September 28, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for STM crossed bullishly above the 50-day moving average on October 01, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.

Following a +7.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where STM advanced for three days, in 205 of 297 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.

STM broke above its upper Bollinger Band on October 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for STM entered a downward trend on September 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. STM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.562) is normal, around the industry mean (7.811). P/E Ratio (103.471) is within average values for comparable stocks, (160.549). Projected Growth (PEG Ratio) (0.195) is also within normal values, averaging (3.705). Dividend Yield (0.007) settles around the average of (0.006) among similar stocks. P/S Ratio (3.370) is also within normal values, averaging (44.558).

The Tickeron Profit vs. Risk Rating rating for this company is 73 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 71, placing this stock worse than average.

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), QUALCOMM (NASDAQ:QCOM), Analog Devices (NASDAQ:ADI).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 213.1B. The market cap for tickers in the group ranges from 86.8K to 5.53T. NVDA holds the highest valuation in this group at 5.53T. The lowest valued company is STRB at 86.8K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was 4%. For the same Industry, the average monthly price growth was 11%, and the average quarterly price growth was 52%. WOLF experienced the highest price growth at 28%, while CBRS experienced the biggest fall at -20%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was 35%. For the same stocks of the Industry, the average monthly volume growth was 30% and the average quarterly volume growth was -37%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 51
Price Growth Rating: 41
SMR Rating: 72
Profit Risk Rating: 71
Seasonality Score: 17 (-100 ... +100)
View a ticker or compare two or three
STM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a broad range of semiconductor integrated circuits and discrete devices

Industry Semiconductors

Industry
Semiconductors
Address
39, Chemin du Champ des Filles
Phone
+41 229292929
Employees
49157
Web
https://www.st.com
Interact to see
Advertisement
United Therapeutics Corporation focuses on biotechnology innovations for chronic and life-threatening conditions, particularly in pulmonary diseases. The company's portfolio centers on treatments for pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF), featuring products like Tyvaso (treprostinil inhalation solution), Orenitram (oral treprostinil), Remodulin, and Adcirca.
SE stock declined -21% over the past 30 days, primarily triggered by a Q4 2025 earnings EPS miss despite revenue beat, leading to a sharp 16% single-day drop. Over the past quarter, the stock fell -37%, reflecting sustained pressure from analyst price target cuts and concerns over rising growth investments.
TaskUs, Inc. (TASK) stands out as a leading provider of outsourced digital services and next-generation customer experience solutions. The company focuses on digital customer experience (Digital CX), trust and safety (monitoring user-generated content for compliance), and artificial intelligence (AI) services such as data labeling and annotation for machine learning models. From its headquarters in New Braunfels, Texas, TaskUs serves high-growth sectors like social media, e-commerce, gaming, streaming, food delivery, ride-sharing, technology, financial services, and healthcare.
WVE stock plunged approximately -52% over the past 30 days, driven primarily by disappointing high-dose data from the Phase 1 INLIGHT trial of obesity candidate WVE-007 on March 26, which erased prior gains from positive initial results. Over the past quarter, shares declined around -61%, reflecting high volatility in biotech sentiment amid clinical trial outcomes and broader sector pressures on clinical-stage firms
KOD stock surged +39% over the past 30 days, driven primarily by positive Phase 3 GLOW2 trial results for Zenkuda in diabetic retinopathy. Over the past quarter, shares gained +36%, reflecting anticipation of clinical catalysts and a successful $184 million capital raise.
Lam Research Corporation stands out as a leading supplier of semiconductor processing equipment essential for fabricating integrated circuits. The company designs, manufactures, markets, refurbishes, and services tools for deposition, etch, and clean processes, serving major chipmakers across the United States, China, Korea, Taiwan, Japan, and Europe. At its core, Lam's business revolves around innovative systems like ALTUS for film deposition and SABRE for electrochemical deposition, which are vital for advanced nodes in AI, memory, and logic chips.
Roblox Corporation (RBLX) runs a platform where millions of users create and dive into immersive 3D experiences. The business centers on a virtual economy: users buy Robux for in-game items, and creators cash out through the developer exchange (DevEx) program. In the online gaming space, Roblox stands out as a metaverse pioneer, going up against the likes of Epic Games' Fortnite and newer AI-driven platforms. The fundamentals reflect impressive user growth—daily active users (DAUs) reached 144 million in Q4 2025, a 69% jump year-over-year—but ongoing net losses underscore the heavy spending on infrastructure, AI, and safety. From what I see, this tension between growth and profitability has fueled much of the recent volatility in RBLX shares, as investors weigh strong engagement against shrinking margins.
Megan Holdings Limited (MGN) is a Malaysia-based company focused on the development, construction, maintenance, and upgrade of aquaculture and agriculture farms, along with related services. At its core, the business provides end-to-end solutions for shrimp farms, from design and building hatcheries to ongoing maintenance. It operates mainly in Sabah, Malaysia, across segments like aquaculture/agriculture, industrial solutions such as smart technologies, and investments in marketable securities.
Megan Holdings Limited (MGN), based in Kuala Lumpur and founded in 2020, focuses on developing, constructing, maintaining, and upgrading aquaculture and agriculture farms in Malaysia. The company operates in three segments—aquaculture and agriculture, industrial solutions like supplying smart technologies and machinery rentals, and investments in marketable securities—carving out a niche in engineering and construction within the Industrials sector. Its subsidiary status under Star Sprite Limited adds a layer of operational stability.
Pony AI Inc. (PONY) stands out as a leading player in autonomous mobility, dedicated to bringing self-driving technology to commercial use. Founded in 2016 and based in Guangzhou, China, the company operates across China, the U.S., and other international markets, offering robotaxi services, robotruck logistics, and licensing for intelligent driving solutions. Its business model leans heavily on asset-light partnerships with original equipment manufacturers (OEMs), transportation network companies (TNCs), and logistics platforms.
Maze Therapeutics, Inc. (MAZE) is a clinical-stage biopharmaceutical company focused on developing small-molecule precision medicines for kidney and metabolic diseases. In my view, the company's core strength lies in its proprietary Maze Compass platform, which uses human genetics and variant functionalization to identify and advance therapies targeting genetically defined patient populations.
In my view, JPM stands out as the largest U.S. bank by assets and market capitalization, commanding leading market shares across key segments. It holds approximately 11.1% of U.S. retail deposits, 23.6% of credit card sales volume, 8.4% of global investment banking fees, 11.8% of markets revenue, and 10% of treasury services revenue. This diversified "universal banking model" spans consumer and community banking, commercial and investment banking, and asset and wealth management, generating resilient revenue streams.
In recent sessions, WMT has held steady around $124, pulling back from February highs near $134. From what I see, this resilience stands out as the stock has outperformed broader indices year-to-date, thanks to its defensive role in groceries and essentials. Shoppers are leaning toward value options, and consistent volumes show ongoing institutional support. The premium valuation reflects confidence in Walmart's omnichannel progress and market share gains. Even with macro headwinds, I view WMT as a portfolio staple during uncertain times.
I've been following ANTX, a biopharmaceutical company based in Menlo Park, California, that develops novel small molecule therapeutics from its proprietary boron chemistry platform. The focus is on underserved areas like infectious diseases, with the lead candidate epetraborole advancing in Phase 3 trials for non-tuberculous mycobacterial (NTM) lung disease and acute melioidosis. The pipeline also includes AN2-502998 for chronic Chagas disease in preclinical stages, along with programs in oncology.
Tilly's, Inc. (TLYS) operates as a specialty retailer specializing in casual apparel, footwear, accessories, and hardgoods aimed at young men, women, boys, and girls. The company focuses on branded fashion inspired by action sports, surf, and skate culture, offering products like tops, bottoms, swimwear, backpacks, hats, and sunglasses from well-known brands such as Vans and Hurley. With approximately 223 stores in malls and lifestyle centers, complemented by e-commerce through www.tillys.com, Tilly's effectively combines physical and digital sales channels.
NKE shares are tumbling approximately 11% in premarket trading on April 1, 2026, sliding to near nine-year lows after the previous close of $52.82. The primary catalyst is Nike's weak Q4 fiscal 2026 guidance: management projected a 2%–4% revenue decline, sharply missing analyst expectations of approximately 1.9% growth.
Aemetis, Inc. (AMTX) is a renewable natural gas and renewable fuels company focused on developing and commercializing low- and negative-carbon intensity products that replace petroleum-based fuels. The company operates through segments including California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. Its core business model centers on converting agricultural waste—such as dairy manure into biogas and corn/wood waste into ethanol—into high-value biofuels like renewable natural gas (RNG), ethanol, biodiesel, and sustainable aviation fuel precursors.
Silvaco Group, Inc. (SVCO) provides technology computer-aided design (TCAD) software, electronic design automation (EDA) software, and semiconductor intellectual property (SIP) solutions. The company helps semiconductor and photonics firms design, simulate, and optimize processes from atomic-level modeling to complex system-on-chip (SoC) development. Its business centers on licensing software tools and IP blocks, along with engineering services, targeting high-growth areas like AI, power devices, automotive, foundries, and 5G/6G mobile.
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.